Literature DB >> 18930823

Use of magnetic resonance imaging for anatomical phenotyping of the R6/2 mouse model of Huntington's disease.

S J Sawiak1, N I Wood, G B Williams, A J Morton, T A Carpenter.   

Abstract

Huntington's disease (HD) is a fatal, inherited neurodegenerative CAG disorder characterized by marked brain atrophy. We used magnetic resonance imaging (MRI) with manual volumetry for three dimensional (3D) morphological phenotyping of ex vivo brains of R6/2 mice, the most commonly used model of HD. High resolution 3D images were acquired for 18 week old wild-type (WT) and R6/2 mice. Although overall brain volumes were the same between genotypes, decreases in volumes were found in the cortex and striatum of R6/2 mice, with significant volume increases in the lateral ventricles and globus pallidus. There was no change in the volume of the amygdala, internal capsule or hippocampal formation. There was a significant increase in signal intensity in the globus pallidus, amygdala, cortex and striatum in R6/2 mice that may reflect neuronal atrophy. This study clearly shows the potential of MRI for morphological phenotyping of rodent models of HD and other neurological diseases. Having obtained proof-of-principle for the technique using ex vivo tissue, it is now our intention to carry out in vivo measurement of developing pathology in HD transgenic mice, and correlate this with behavioral deficits.

Entities:  

Mesh:

Year:  2008        PMID: 18930823     DOI: 10.1016/j.nbd.2008.09.017

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  31 in total

1.  Reduced expression of conditioned fear in the R6/2 mouse model of Huntington's disease is related to abnormal activity in prelimbic cortex.

Authors:  Adam G Walker; Jason R Ummel; George V Rebec
Journal:  Neurobiol Dis       Date:  2011-04-16       Impact factor: 5.996

Review 2.  Huntington's disease: can mice lead the way to treatment?

Authors:  Zachary R Crook; David Housman
Journal:  Neuron       Date:  2011-02-10       Impact factor: 17.173

3.  Stress-induced grey matter loss determined by MRI is primarily due to loss of dendrites and their synapses.

Authors:  Mustafa S Kassem; Jim Lagopoulos; Tim Stait-Gardner; William S Price; Tariq W Chohan; Jonathon C Arnold; Sean N Hatton; Maxwell R Bennett
Journal:  Mol Neurobiol       Date:  2012-11-09       Impact factor: 5.590

4.  Spatiotemporal mapping of brain atrophy in mouse models of Huntington's disease using longitudinal in vivo magnetic resonance imaging.

Authors:  Manisha Aggarwal; Wenzhen Duan; Zhipeng Hou; Neal Rakesh; Qi Peng; Christopher A Ross; Michael I Miller; Susumu Mori; Jiangyang Zhang
Journal:  Neuroimage       Date:  2012-02-09       Impact factor: 6.556

5.  Evidence from the R6/2 Mouse Model of Huntington's Disease for Using Abnormal Brain Metabolism as a Biomarker for Evaluating Therapeutic Approaches for Treatment.

Authors:  Anna Parievsky; Carlos Cepeda; Michael S Levine
Journal:  Future Neurol       Date:  2012

6.  Automated detection of amyloid-β-related cortical and subcortical signal changes in a transgenic model of Alzheimer's disease using high-field MRI.

Authors:  Stefan J Teipel; Evangelia Kaza; Stefan Hadlich; Alexandra Bauer; Thomas Brüning; Anne-Sophie Plath; Markus Krohn; Katja Scheffler; Lary C Walker; Martin Lotze; Jens Pahnke
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

7.  Structural MRI detects progressive regional brain atrophy and neuroprotective effects in N171-82Q Huntington's disease mouse model.

Authors:  Yong Cheng; Qi Peng; Zhipeng Hou; Manisha Aggarwal; Jiangyang Zhang; Susumu Mori; Christopher A Ross; Wenzhen Duan
Journal:  Neuroimage       Date:  2011-02-12       Impact factor: 6.556

8.  Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.HttQ111/+ model of Huntington's disease.

Authors:  Robert M Bragg; Sydney R Coffey; Rory M Weston; Seth A Ament; Jeffrey P Cantle; Shawn Minnig; Cory C Funk; Dominic D Shuttleworth; Emily L Woods; Bonnie R Sullivan; Lindsey Jones; Anne Glickenhaus; John S Anderson; Michael D Anderson; Stephen B Dunnett; Vanessa C Wheeler; Marcy E MacDonald; Simon P Brooks; Nathan D Price; Jeffrey B Carroll
Journal:  Sci Rep       Date:  2017-02-08       Impact factor: 4.379

9.  Longitudinal characterization of brain atrophy of a Huntington's disease mouse model by automated morphological analyses of magnetic resonance images.

Authors:  Jiangyang Zhang; Qi Peng; Qing Li; Neda Jahanshad; Zhipeng Hou; Mali Jiang; Naoki Masuda; Douglas R Langbehn; Michael I Miller; Susumu Mori; Christopher A Ross; Wenzhen Duan
Journal:  Neuroimage       Date:  2009-10-19       Impact factor: 6.556

Review 10.  Magnetic resonance imaging of Huntington's disease: preparing for clinical trials.

Authors:  S Klöppel; S M Henley; N Z Hobbs; R C Wolf; J Kassubek; S J Tabrizi; R S J Frackowiak
Journal:  Neuroscience       Date:  2009-01-29       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.